https://www.selleckchem.com/products/s961.html
vascular diseases (CVD), inflammation, transplantation, autoimmune disease and cancers.This study aimed to investigate the predictive value of liver metastases (LM) in patients with various advanced cancers received immune-checkpoint inhibitors (ICIs). First, clinical and survival data from a published cohort of 1,661 patients who received ICIs therapy were downloaded and analyzed. Second, a retrospective review of 182 patients with advanced non-small-cell lung cancer (NSCLC) who received PD-1/PD-L1 monotherapy was identified. Third, a met
Aimer
Commentaire
Partagez
